|
|
Article: Largest Global Study Launched to Examine Patient Adherence to Drug Therapy in Multiple Sclerosis and Renagel Study in New Dialysis Patients Published in Kidney International.
- Article from:
- M2 Presswire
- Article date:
- September 30, 2005
CopyrightCOPYRIGHT 2005 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-30 September 2005-US Financial Network: Largest Global Study Launched to Examine Patient Adherence to Drug Therapy in Multiple Sclerosis and Renagel Study in New Dialysis Patients Published in Kidney International(C)1994-2005 M2 COMMUNICATIONS LTD
RDATE:30092005
City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU) Biogen Idec (NASDAQ:BIIB) announced recently the initiation of the Global Adherence Project (GAP), the largest multi-national study of its kind to date to evaluate patient adherence to long-term treatments for multiple sclerosis (MS) in a real-world setting. In collaboration with patients ...
Related newspaper, magazine, and journal articles:
|
|
Article: News Search Engine, NewsKnowledge.com, Now Distributing ...
M2 Presswire;
January 12, 2005 ;
700+ words
... ... NewsKnowledge.com, Now Distributing Financial News USA News Feed(C)1994-2005 ... 01122005 City of Industry, CA - Financial News USA (OTC: FNWU), a next generation ... analyzing the actual web pages. Financial News USA recently announced that it ...
|
|